{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:15:06Z","timestamp":1778523306379,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973159"],"award-info":[{"award-number":["81973159"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903430"],"award-info":[{"award-number":["81903430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["lzujbky- 2021-pd05"],"award-info":[{"award-number":["lzujbky- 2021-pd05"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["22JR5RA545"],"award-info":[{"award-number":["22JR5RA545"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jpain.2022.12.012","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T20:22:56Z","timestamp":1672258976000},"page":"840-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["NaV1.7 Channel Blocker [Ala5, Phe6, Leu26, Arg28]GpTx-1 Attenuates CFA-induced Inflammatory Hypersensitivity in Rats via Endogenous Enkephalin Mechanism"],"prefix":"10.1016","volume":"24","author":[{"given":"Biao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanran","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0381-6796","authenticated-orcid":false,"given":"Quan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2022.12.012_bib0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/164_2017_32","article-title":"The delta opioid receptor in pain control","volume":"247","author":"Abdallah","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0002","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins9080248","article-title":"Lengths of the C-terminus and interconnecting loops impact stability of spider-derived gating modifier toxins","volume":"9","author":"Agwa","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jpain.2022.12.012_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152405","article-title":"Subtype-selective small molecule inhibitors reveal a fundamental role for nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release","volume":"11","author":"Alexandrou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2022.12.012_bib0004","doi-asserted-by":"crossref","first-page":"eaax4568","DOI":"10.1126\/sciadv.aax4568","article-title":"Sensory neuron-derived NaV1.7 contributes to dorsal horn neuron excitability","volume":"6","author":"Alles","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jpain.2022.12.012_bib0005","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0306-4522(01)00034-3","article-title":"Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats","volume":"103","author":"Antunes bras","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2022.12.012_bib0006","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jpain.2022.12.012_bib0007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1474-4422(14)70024-9","article-title":"Painful and painless channelopathies","volume":"13","author":"Bennett","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0008","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1021\/acschembio.7b00542","article-title":"Engineering antibody reactivity for efficient derivatization to generate nav1.7 inhibitory gptx-1 peptide-antibody conjugates","volume":"12","author":"Biswas","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0009","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1744-8069-8-82","article-title":"Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn","volume":"8","author":"Black","year":"2012","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2022.12.012_bib0010","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1523\/JNEUROSCI.21-19-07598.2001","article-title":"Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception","volume":"21","author":"Cahill","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2022.12.012_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.551065","article-title":"Integration of transcriptome resequencing and quantitative proteomics analyses of collagenase VII-induced intracerebral hemorrhage in mice","volume":"11","author":"Cao","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.jpain.2022.12.012_bib0012","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1111\/bph.14461","article-title":"GpTx-1 and [Ala5, Phe6, Leu26, Arg28]GpTx-1, two peptide NaV1.7 inhibitors: analgesic and tolerance properties at the spinal level","volume":"175","author":"Chen","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0013","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1440-1681.1999.03049.x","article-title":"Opioid receptor signalling mechanisms","volume":"26","author":"Connor","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0014","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"Woods CG: An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jpain.2022.12.012_bib0015","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications","volume":"58","author":"de Lera Ruiz","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2022.12.012_bib0016","doi-asserted-by":"crossref","first-page":"40883","DOI":"10.1038\/srep40883","article-title":"Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a","volume":"7","author":"Deuis","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpain.2022.12.012_bib0017","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/toxins8030078","article-title":"Analgesic effects of GpTx-1, PF-04856264 and CNV1014802 in a mouse model of nav1.7-mediated pain","volume":"8","author":"Deuis","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jpain.2022.12.012_bib0018","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1460-9568.2010.07466.x","article-title":"Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice","volume":"32","author":"Dubois","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jpain.2022.12.012_bib0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.peptides.2015.05.013","article-title":"[des-Arg(1)]-Proctolin: A novel NEP-like enzyme inhibitor identified in Tityus serrulatus venom","volume":"80","author":"Duzzi","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.jpain.2022.12.012_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/bph.12895","article-title":"The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating beta-endorphin release from spinal microglia","volume":"172","author":"Fan","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1744-8069-9-13","article-title":"Intervention of electroacupuncture on spinal p38 MAPK\/ATF-2\/VR-1 pathway in treating inflammatory pain induced by CFA in rats","volume":"9","author":"Fang","year":"2013","journal-title":"Mol Pain"},{"key":"10.1016\/j.jpain.2022.12.012_bib0022","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/bph.13448","article-title":"PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase","volume":"173","author":"Freitas","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1742-7843.2005.pto_97107.x","article-title":"A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80","volume":"97","author":"Gallantine","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0024","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1111\/j.1460-9568.2008.06223.x","article-title":"Inflammatory pain is enhanced in delta opioid receptor-knockout mice","volume":"27","author":"Gaveriaux-Ruff","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jpain.2022.12.012_bib0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1399-0004.2007.00790.x","article-title":"Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations","volume":"71","author":"Goldberg","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.jpain.2022.12.012_bib0026","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1073\/pnas.2000712117","article-title":"Biased signaling by endogenous opioid peptides","volume":"117","author":"Gomes","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2022.12.012_bib0027","doi-asserted-by":"crossref","first-page":"eaah4874","DOI":"10.1126\/scisignal.aah4874","article-title":"Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice","volume":"10","author":"Isensee","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/j.jpain.2022.12.012_bib0028","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apha.2017.01.004","article-title":"Sodium channels and venom peptide pharmacology","volume":"79","author":"Israel","year":"2017","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2220\/biomedres.26.123","article-title":"Nerve growth factor-induced hyperexcitability of rat sensory neuron in culture","volume":"26","author":"Kitamura","year":"2005","journal-title":"Biomed Res"},{"key":"10.1016\/j.jpain.2022.12.012_bib0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.116.239590","article-title":"Pharmacologic characterization of AMG8379, a potent and selective small molecule sulfonamide antagonist of the voltage-gated sodium channel nav1.7","volume":"362","author":"Kornecook","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2022.12.012_bib0031","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/acschembio.8b00989","article-title":"Peptide-membrane interactions affect the inhibitory potency and selectivity of spider toxins protx-ii and gptx-1","volume":"14","author":"Lawrence","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0032","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/JPR.S207610","article-title":"Voltage gated sodium channels as therapeutic targets for chronic pain","volume":"12","author":"Ma","year":"2019","journal-title":"J Pain Res"},{"key":"10.1016\/j.jpain.2022.12.012_bib0033","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.neuron.2021.03.012","article-title":"A central mechanism of analgesia in mice and humans lacking the sodium channel NaV1.7","volume":"109","author":"MacDonald","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.jpain.2022.12.012_bib0034","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cne.22130","article-title":"Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study","volume":"517","author":"Marvizon","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0035","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/j.pain.0000000000001227","article-title":"Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy","volume":"159","author":"McDonnell","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.12.012_bib0036","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.celrep.2013.12.033","article-title":"Pain without nociceptors? Nav1.7-independent pain mechanisms","volume":"6","author":"Minett","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpain.2022.12.012_bib0037","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ncomms1795","article-title":"Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons","volume":"3","author":"Minett","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpain.2022.12.012_bib0038","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.1038\/ncomms9967","article-title":"Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7","volume":"6","author":"Minett","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpain.2022.12.012_bib0039","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s10753-011-9420-7","article-title":"Synergism between fentanyl and tramadol in tonic inflammatory pain: the orofacial formalin test","volume":"35","author":"Miranda","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.jpain.2022.12.012_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196791","article-title":"Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V","volume":"13","author":"Moyer","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2022.12.012_bib0041","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/j.pain.0000000000001567","article-title":"Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen","volume":"160","author":"Mueller","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2022.12.012_bib0042","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1016\/j.bmcl.2015.06.033","article-title":"Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1","volume":"25","author":"Murray","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpain.2022.12.012_bib0043","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/jm501765v","article-title":"Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the NaV1.7 sodium channel","volume":"58","author":"Murray","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2022.12.012_bib0044","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1021\/acs.jmedchem.5b01947","article-title":"Single residue substitutions that confer voltage-gated sodium ion channel subtype selectivity in the nav1.7 inhibitory peptide gptx-1","volume":"59","author":"Murray","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2022.12.012_bib0045","doi-asserted-by":"crossref","first-page":"12706","DOI":"10.1073\/pnas.0404915101","article-title":"Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain","volume":"101","author":"Nassar","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2022.12.012_bib0046","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1152\/jn.01122.2015","article-title":"Development of a spontaneously active dorsal root ganglia assay using multiwell multielectrode arrays","volume":"115","author":"Newberry","year":"2016","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0047","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.toxicon.2011.06.006","article-title":"Characterization of voltage-dependent calcium channel blocking peptides from the venom of the tarantula Grammostola rosea","volume":"58","author":"Ono","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.jpain.2022.12.012_bib0048","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/164_2018_97","article-title":"Selective ligands and drug discovery targeting the voltage-gated sodium channel Nav1.7","volume":"246","author":"Payandeh","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0049","doi-asserted-by":"crossref","first-page":"101","DOI":"10.12688\/wellcomeopenres.14687.1","article-title":"Analgesia linked to Nav1.7 loss of function requires micro- and delta-opioid receptors","volume":"3","author":"Pereira","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jpain.2022.12.012_bib0050","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.cell.2009.04.019","article-title":"Dissociation of the opioid receptor mechanisms that control mechanical and heat pain","volume":"137","author":"Scherrer","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jpain.2022.12.012_bib0051","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cts.12712","article-title":"Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Nav1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects","volume":"13","author":"Siebenga","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jpain.2022.12.012_bib0052","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/acschemneuro.7b00406","article-title":"Selective voltage-gated sodium channel peptide toxins from animal venom: pharmacological probes and analgesic drug development","volume":"9","author":"Wu","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jpain.2022.12.012_bib0053","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14848","article-title":"The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via mu- and kappa-opioid receptors","volume":"177","author":"Xu","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2022.12.012_bib0054","doi-asserted-by":"crossref","first-page":"15709","DOI":"10.1021\/acs.jmedchem.0c01367","article-title":"Synthesis and biological characterization of cyclic disulfide-containing peptide analogs of the multifunctional opioid\/neuropeptide ff receptor agonists that produce long-lasting and nontolerant antinociception","volume":"63","author":"Zhang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2022.12.012_bib0055","doi-asserted-by":"crossref","first-page":"13394","DOI":"10.1021\/acs.jmedchem.1c00694","article-title":"Development of multifunctional and orally active cyclic peptide agonists of opioid\/neuropeptide ff receptors that produce potent, long-lasting, and peripherally restricted antinociception with diminished side effects","volume":"64","author":"Zhang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2022.12.012_bib0056","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12974-018-1154-0","article-title":"Glial interleukin-1beta upregulates neuronal sodium channel 1.7 in trigeminal ganglion contributing to temporomandibular joint inflammatory hypernociception in rats","volume":"15","author":"Zhang","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jpain.2022.12.012_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173169","article-title":"Spinal administration of the multi-functional opioid\/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia","volume":"880","author":"Zhang","year":"2020","journal-title":"Eur J Pharmacol"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590022004813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590022004813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:52:12Z","timestamp":1778521932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590022004813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1526590022004813"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2022.12.012","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NaV1.7 Channel Blocker [Ala5, Phe6, Leu26, Arg28]GpTx-1 Attenuates CFA-induced Inflammatory Hypersensitivity in Rats via Endogenous Enkephalin Mechanism","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by United States Association for the Study of Pain, Inc.","name":"copyright","label":"Copyright"}]}}